Theraly Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Theraly Pharmaceuticals General Information

Description

Operator of a pharmaceutical preparations company. The company offers customized technologies to meet the business needs.

Contact Information

Website
www.theraly.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 9725 Clocktower Lane
  • Apartment 202
  • Columbia, MD 21046
  • United States
Primary Industry
Drug Discovery
Vertical(s)
TMT
Corporate Office
  • 9725 Clocktower Lane
  • Apartment 202
  • Columbia, MD 21046
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theraly Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jun-2019 Completed Out of Business
2. Accelerator/Incubator 17-Feb-2017 Completed Startup
1. Grant 16-Sep-2015 $100K Completed Startup
To view Theraly Pharmaceuticals’s complete valuation and funding history, request access »

Theraly Pharmaceuticals Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Theraly Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018058879-A Trail receptor agonists for treatment of fibrotic disease Pending 21-Apr-2014
ES-2674581-T3 Pegylated exendin-4 analogue with polyethylene glycol or derivative thereof, method of preparation thereof and pharmaceutical composition to prevent or treat diabetes, which contains the same as active ingredient Active 28-Jun-2011
US-20130217622-A1 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical compostion for preventing or treating diabetes, containing same as active ingredient Inactive 28-Jun-2011
EP-2727605-A2 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient Active 28-Jun-2011
EP-2727605-B1 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient Active 28-Jun-2011 A61K47/02
To view Theraly Pharmaceuticals’s complete patent history, request access »

Ready to get started?

Request a free trial

Theraly Pharmaceuticals FAQs

  • When was Theraly Pharmaceuticals founded?

    Theraly Pharmaceuticals was founded in 2005.

  • Where is Theraly Pharmaceuticals headquartered?

    Theraly Pharmaceuticals is headquartered in Columbia, MD.

  • What industry is Theraly Pharmaceuticals in?

    Theraly Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Theraly Pharmaceuticals a private or public company?

    Theraly Pharmaceuticals is a Private company.

  • What is Theraly Pharmaceuticals’s current revenue?

    The current revenue for Theraly Pharmaceuticals is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »